International Patent: ACTR II B FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF

GENEVA, July 27 -- SHENYANG SUNSHINE PHARMACEUTICAL CO., LTD. filed a patent application (CN2026/072397) for “ACTR II B FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF”. With publication no. WO/2026/153330, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/705

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....